![](/img/cover-not-exists.png)
PND4 ESTIMATED COST SAVINGS WHEN TREATING RESTLESS LEGS SYNDROME (RLS) WITH GABAPENTIN ENACARBIL IN THE US
R Allen, M Bharmal, R Manjunath, M CallowayVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72666-8
File:
PDF, 95 KB
english, 2010